Slide 1The Role of Biotechnology and Bioinformatics in FDAs Critical Path Initiative Janet Woodcock M.D. Deputy Commissioner/Chief Medical Officer US Food and Drug Administration…
Slide 1Imperfect Gold Standards for Biomarker Evaluation Rebecca A. Betensky Conference on Statistical Issues in Clinical Trials University of Pennsylvania April 18, 2012…
Slide 1Innovation or Stagnation - Perspective of Pharmaceutical Industry AGAH Annual Meeting 2006 21 February 2006 Dr. Siegfried Throm Director Research, Development, Innovation…
1.RESEARCH UPDATEThe following is an overview of the research being conducted worldwide that is relevant to the NephCure Community. Please note that this is an analysis ofcurrent…
1.Franck Molina, Montpellier, [email protected]://sysdiag.cnrs.frPrivate Public collaboration to boost open innovation2. Diagnostic in mutation+5-6%+14-15%Change…
1. Presented by: Ms. Suruchi Ramkumar Sharma F.Y. M.Pharm Under the guidance of: Dr. (Mrs.) Vaishali Dixit M.E.T Institute of Pharmacy, Bandra (W) 12-Mar-2012 2. Definition:…
1. 11/4/2005 | Volume: 5 | number 42 in this issueFeatures Waters Develops New Label-Free, Mass Spec- Based Method for Absolute Quantification The new method relies on an…